Clinical trials recruiting for Mesial Temporal Lobe Epilepsy
3
Recruiting trials
27
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Phase 3 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AAV9-hSyn1-miGRIK2 | 1 |
| NRTX-1001 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Texas | 3 |
| Alabama | 2 |
| Arizona | 2 |
| California | 2 |
| Florida | 2 |
| Massachusetts | 2 |
| Michigan | 2 |
| New Hampshire | 2 |
| Pennsylvania | 2 |
| Wisconsin | 2 |
| Arkansas | 1 |
| Colorado | 1 |
Top cities
Birmingham, Alabama 2Boston, Massachusetts 2Houston, Texas 2Lebanon, New Hampshire 2Milwaukee, Wisconsin 2Palo Alto, California 2Philadelphia, Pennsylvania 2Phoenix, Arizona 2Aurora, Colorado 1Austin, Texas 1
Self-screener
Recruiting trials
- AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- PRIME: PReservIng Memory in Epilepsy
- Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Related conditions
Trials recruiting for Mesial Temporal Lobe Epilepsy often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Mesial Temporal Lobe Epilepsy trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.